|
CA2264819C
(en)
*
|
1996-09-04 |
2010-03-23 |
Intertrust Technologies Corp. |
Trusted infrastructure support systems, methods and techniques for secure electronic commerce, electronic transactions, commerce process control and automation, distributed computing, and rights management
|
|
PT2041139E
(pt)
*
|
2006-04-26 |
2012-01-13 |
Hoffmann La Roche |
Compostos farmacêuticos
|
|
MX2008013583A
(es)
|
2006-04-26 |
2008-10-31 |
Genentech Inc |
Compuestos del inhibidor de fosfoinositido 3-cinasa y composiciones farmaceuticas que los contienen.
|
|
AR064155A1
(es)
|
2006-12-07 |
2009-03-18 |
Piramed Ltd |
Compuestos de inhibidores de fosfoinositido-3 quinasa y metodos de uso
|
|
WO2008073785A2
(en)
*
|
2006-12-07 |
2008-06-19 |
Genentech, Inc. |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
|
CN101616672A
(zh)
*
|
2007-02-20 |
2009-12-30 |
诺瓦提斯公司 |
作为脂质激酶和mTOR双重抑制剂的咪唑并喹啉类
|
|
JP5539190B2
(ja)
*
|
2007-06-12 |
2014-07-02 |
エフ．ホフマン−ラ ロシュ アーゲー |
チアゾロピリミジン類及びホスファチジルイノシトール−３キナーゼのインヒビターとしてのそれらの使用
|
|
TWI471134B
(zh)
*
|
2007-09-12 |
2015-02-01 |
Genentech Inc |
肌醇磷脂３－激酶抑制劑化合物及化療劑之組合及使用方法
|
|
ES2399774T3
(es)
|
2007-09-24 |
2013-04-03 |
Genentech, Inc. |
Compuestos de tiazolopirimidina inhibidores de PI3K y métodos de uso
|
|
CA2701292C
(en)
*
|
2007-10-25 |
2015-03-24 |
Genentech, Inc. |
Process for making thienopyrimidine compounds
|
|
GB0721095D0
(en)
*
|
2007-10-26 |
2007-12-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
CA2703138A1
(en)
*
|
2007-10-26 |
2009-04-30 |
F. Hoffmann-La Roche Ag |
Purine derivatives useful as pi3 kinase inhibitors
|
|
KR101760758B1
(ko)
|
2008-05-14 |
2017-07-24 |
애그리컬쳐 빅토리아 서비스 피티와이 엘티디 |
질병 및 장애를 치료하기 위한 안지오게닌 또는 안지오게닌 아고니스트의 이용
|
|
US8158624B2
(en)
*
|
2008-05-30 |
2012-04-17 |
Genetech, Inc. |
Purine PI3K inhibitor compounds and methods of use
|
|
KR20110046514A
(ko)
*
|
2008-07-31 |
2011-05-04 |
제넨테크, 인크. |
피리미딘 화합물, 조성물 및 사용 방법
|
|
TWI378933B
(en)
|
2008-10-14 |
2012-12-11 |
Daiichi Sankyo Co Ltd |
Morpholinopurine derivatives
|
|
WO2010042998A1
(en)
|
2008-10-17 |
2010-04-22 |
Akaal Pharma Pty Ltd |
S1p receptors modulators
|
|
WO2010043000A1
(en)
|
2008-10-17 |
2010-04-22 |
Akaal Pharma Pty Ltd |
S1p receptors modulators and their use thereof
|
|
JP5877064B2
(ja)
*
|
2008-11-11 |
2016-03-02 |
エックスカバリー ホールディング カンパニー エルエルシー |
ＰＩ３Ｋ／ｍＴＯＲキナーゼ阻害剤
|
|
US8653098B2
(en)
|
2008-11-20 |
2014-02-18 |
Genentech, Inc. |
Pyrazolopyridine PI3K inhibitor compounds and methods of use
|
|
KR101829595B1
(ko)
|
2009-01-08 |
2018-02-14 |
메르크 파텐트 게엠베하 |
3-（1-｛3-［5-（1-메틸-피페리딘-4일메톡시）-피리미딘-2-일］-벤질｝-6-옥소-1,6-디히드로-피리다진-3-일）-벤조니트릴 히드로클로라이드 염의 신규한 다형체 및 이의 제조 방법
|
|
ME02230B
(me)
*
|
2009-01-08 |
2016-02-20 |
Curis Inc |
Inhibitori fosfoinozitid 3-kinaze sa delom koji vezuje cink
|
|
CA2753285A1
(en)
|
2009-03-12 |
2010-09-16 |
Genentech, Inc. |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
|
|
CA2754890C
(en)
*
|
2009-03-13 |
2018-01-16 |
Piet Herdewijn |
Bicyclic heterocycles
|
|
CN102361878A
(zh)
|
2009-03-24 |
2012-02-22 |
住友化学株式会社 |
用于制备硼酸酯化合物的方法
|
|
JP5766177B2
(ja)
*
|
2009-03-27 |
2015-08-19 |
ベトディーシー，インコーポレイテッド |
ピリミジニル及び１，３，５−トリアジニルベンゾイミダゾールスルホンアミド及びガンの療法におけるその使用
|
|
CA2761445A1
(en)
*
|
2009-05-27 |
2010-12-02 |
Genentech, Inc. |
Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
EP2451811A1
(en)
*
|
2009-05-27 |
2012-05-16 |
F. Hoffmann-La Roche AG |
Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
CN102480961A
(zh)
*
|
2009-06-24 |
2012-05-30 |
健泰科生物技术公司 |
与含氧杂环稠合的嘧啶化合物、组合物和使用方法
|
|
EP2532659A1
(en)
|
2009-07-07 |
2012-12-12 |
Pathway Therapeutics, Inc. |
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
|
|
AU2010279384A1
(en)
*
|
2009-08-05 |
2012-03-01 |
Wake Forest University |
Compositions and methods for inducing apoptosis in prostate cancer cells
|
|
HRP20190016T1
(hr)
|
2009-08-17 |
2019-03-08 |
Intellikine, Llc |
Heterociklički spojevi i njihova upotreba
|
|
PL2467387T3
(pl)
*
|
2009-08-20 |
2015-08-31 |
Karus Therapeutics Ltd |
Tricykliczne związki heterocykliczne jako inhibitory kinazy 3-fosfoinozytydu
|
|
WO2011031896A2
(en)
*
|
2009-09-09 |
2011-03-17 |
Avila Therapeutics, Inc. |
Pi3 kinase inhibitors and uses thereof
|
|
WO2011030312A1
(en)
*
|
2009-09-10 |
2011-03-17 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
|
|
AU2010299820A1
(en)
|
2009-09-28 |
2012-04-19 |
F. Hoffmann-La Roche Ag |
Benzoxepin PI3K inhibitor compounds and methods of use
|
|
WO2011049625A1
(en)
|
2009-10-20 |
2011-04-28 |
Mansour Samadpour |
Method for aflatoxin screening of products
|
|
HRP20171537T1
(hr)
|
2009-11-05 |
2017-12-15 |
Rhizen Pharmaceuticals S.A. |
Novi modulatori benzopiran kinaze
|
|
BR112012011147A2
(pt)
*
|
2009-11-12 |
2021-09-08 |
F.Hoffmann-La Roche Ag |
Composto, composição farmacêutica e uso de um composto.
|
|
MX2012005463A
(es)
*
|
2009-11-12 |
2012-09-12 |
Hoffmann La Roche |
Compuestos de purina n/9 sustituida, composiciones y metodos de uso.
|
|
US8633183B2
(en)
*
|
2010-01-26 |
2014-01-21 |
Boehringer Ingelheim International Gmbh |
5-alkynyl-pyrimidines
|
|
US8440651B2
(en)
|
2010-02-22 |
2013-05-14 |
F. Hoffmann-La Roche Ag |
Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use
|
|
UY33304A
(es)
*
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
|
CN103003279B
(zh)
|
2010-07-14 |
2015-09-23 |
弗·哈夫曼-拉罗切有限公司 |
对PI3K P110δ具有选择性的嘌呤化合物及其使用方法
|
|
EP3053925A1
(en)
*
|
2010-12-16 |
2016-08-10 |
F. Hoffmann-La Roche AG |
Tricyclic pi3k inhibitor compounds and methods of use
|
|
JP2014505076A
(ja)
*
|
2011-01-27 |
2014-02-27 |
ザ トラスティーズ オブ プリンストン ユニバーシティ |
抗ウイルス剤としてのｍＴＯＲキナーゼの阻害剤
|
|
US8653089B2
(en)
|
2011-02-09 |
2014-02-18 |
F. Hoffmann-La Roche Ag |
Heterocyclic compounds and methods of use
|
|
RU2013143747A
(ru)
|
2011-03-21 |
2015-04-27 |
Ф. Хоффманн-Ля Рош Аг |
Соединения бензоксазепина, селективные в отношении pi3k p110 дельта и способы их применения
|
|
JP6042406B2
(ja)
|
2011-03-28 |
2016-12-14 |
メイ プハルマ，インコーポレーテッド |
（α−置換アラルキルアミノ及びヘテロアリールアルキルアミノ）ピリミジニル及び１，３，５−トリアジニルベンズイミダゾール、それらを含む医薬組成物、並びに増殖性疾患の治療で使用するためのこれらの化合物
|
|
PE20141382A1
(es)
|
2011-04-01 |
2014-11-04 |
Curis Inc |
Inhibidor de la fosfoinositida-3-quinasa con un grupo de union a zinc
|
|
KR101992311B1
(ko)
|
2011-05-04 |
2019-09-27 |
리젠 파마슈티컬스 소시에떼 아노님 |
단백질 키나아제의 조절제로서 신규한 화합물
|
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
|
KR101255939B1
(ko)
*
|
2011-05-31 |
2013-04-23 |
동화약품주식회사 |
4-(1ｈ-인다졸-6-일아미노)-ｎ-아이소프로필-2-(메틸티오)피리미딘-5-카르복스아미드 화합물 또는 이의 약학적으로 허용가능한 염을 포함하는 당뇨병 예방 또는 치료용 조성물
|
|
RU2603462C2
(ru)
*
|
2011-10-13 |
2016-11-27 |
Дженентек, Инк. |
Лечение фармакологически индуцированной гипохлоргидрии
|
|
CA2855666A1
(en)
*
|
2011-11-11 |
2013-05-16 |
Intellikine, Llc |
Combination of kinase inhibitors and uses thereof
|
|
CN102643272B
(zh)
*
|
2011-12-30 |
2015-03-11 |
沈阳药科大学 |
新的噻吩并[3,2-d]嘧啶类化合物
|
|
GB201204125D0
(en)
|
2012-03-08 |
2012-04-25 |
Karus Therapeutics Ltd |
Compounds
|
|
FR2988722B1
(fr)
|
2012-04-03 |
2014-05-09 |
Sanofi Sa |
Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
|
|
WO2013152717A1
(zh)
|
2012-04-10 |
2013-10-17 |
上海昀怡健康管理咨询有限公司 |
稠合嘧啶类化合物，其制备方法，中间体，组合物和应用
|
|
US9801863B2
(en)
|
2012-04-16 |
2017-10-31 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
|
|
EP3295940A1
(en)
|
2012-04-16 |
2018-03-21 |
Case Western Reserve University |
Compositions and methods of modulating 15-pgdh activity
|
|
PT2848254T
(pt)
*
|
2012-05-07 |
2016-10-05 |
Kissei Pharmaceutical |
Derivado de pirazol e utilização do mesmo para propósitos médicos
|
|
AU2013204740C1
(en)
|
2012-05-10 |
2015-10-01 |
Agriculture Victoria Services Pty Ltd |
Methods of treating cancer using angiogenin or an angiogenin agonist
|
|
KR20160027218A
(ko)
|
2012-05-23 |
2016-03-09 |
에프. 호프만-라 로슈 아게 |
내배엽 및 간세포를 수득하고 사용하는 조성물 및 방법
|
|
KR101915942B1
(ko)
|
2012-06-08 |
2018-11-06 |
에프. 호프만-라 로슈 아게 |
암의 치료를 위한 포스포이노시타이드 3 키나제 억제제 화합물 및 화학치료제의 돌연변이체 선택성 및 조합물
|
|
LT2870157T
(lt)
|
2012-07-04 |
2017-12-11 |
Rhizen Pharmaceuticals S.A. |
Selektyvieji pi3k delta inhibitoriai
|
|
CN104583215B
(zh)
*
|
2012-08-30 |
2016-12-07 |
霍夫曼-拉罗奇有限公司 |
二噁烯并-和噁嗪-[2,3-d]嘧啶pi3k抑制剂化合物及使用方法
|
|
EP2914260A1
(en)
|
2012-10-31 |
2015-09-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for preventing antiphospholipid syndrome (aps)
|
|
MX364295B
(es)
|
2012-11-07 |
2019-04-22 |
Karus Therapeutics Ltd |
Inhibidores de histona desacetilasa novedosos y su uso en terapia.
|
|
CA2909310A1
(en)
|
2013-04-12 |
2014-10-16 |
Asana Biosciences, Llc |
Quinazolines and azaquinazolines as dual inhibitors of ras/raf/mek/erk and pi3k/akt/pten/mtor pathways
|
|
SMT201800501T1
(it)
|
2013-05-10 |
2018-11-09 |
Karus Therapeutics Ltd |
Nuovi inibitori di istone deacetilasi
|
|
DE102013008118A1
(de)
*
|
2013-05-11 |
2014-11-13 |
Merck Patent Gmbh |
Arylchinazoline
|
|
WO2014203129A1
(en)
|
2013-06-19 |
2014-12-24 |
Olema Pharmaceuticals, Inc. |
Combinations of benzopyran compounds, compositions and uses thereof
|
|
US9745321B2
(en)
|
2013-09-30 |
2017-08-29 |
Shanghai Yingli Pharmaceutical Co., Ltd |
Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereof
|
|
US9789116B2
(en)
|
2013-10-15 |
2017-10-17 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
CN104557872B
(zh)
|
2013-10-16 |
2017-05-24 |
上海璎黎药业有限公司 |
稠合杂环化合物、其制备方法、药物组合物和用途
|
|
KR20160118345A
(ko)
|
2014-02-06 |
2016-10-11 |
애브비 인코포레이티드 |
6-헤테로아릴옥시- 및 6-아릴옥시-퀴놀린-2-카복사미드 및 이의 용도
|
|
GB201402431D0
(en)
|
2014-02-12 |
2014-03-26 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201419228D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201419264D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
CN107921025A
(zh)
|
2015-03-08 |
2018-04-17 |
卡斯西部储备大学 |
用于治疗纤维症的短链脱氢酶活性的抑制剂
|
|
US20180057505A1
(en)
*
|
2015-03-20 |
2018-03-01 |
Vertex Pharmaceuticals Incorporated |
Bicyclic heteroaryl compounds useful as inhibitors of the par-2 signaling pathway
|
|
AR104068A1
(es)
|
2015-03-26 |
2017-06-21 |
Hoffmann La Roche |
Combinaciones de un compuesto inhibidor de fosfoinosítido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cáncer
|
|
TWI689508B
(zh)
*
|
2015-03-30 |
2020-04-01 |
日商第一三共股份有限公司 |
可作爲ｐｉ３ｋ抑制劑之吡唑衍生物及其用途
|
|
JP2018511616A
(ja)
*
|
2015-04-14 |
2018-04-26 |
ケース ウエスタン リザーブ ユニバーシティ |
短鎖デヒドロゲナーゼ活性を調節する組成物および方法
|
|
HK1249866A1
(zh)
|
2015-06-29 |
2018-11-16 |
豪夫迈‧罗氏有限公司 |
用他塞利昔布进行治疗的方法
|
|
GB201514754D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201514751D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201514760D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds and method of use
|
|
GB201514758D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Formulation
|
|
AU2016378723B2
(en)
|
2015-12-22 |
2021-09-30 |
SHY Therapeutics LLC |
Compounds for the treatment of cancer and inflammatory disease
|
|
CN107098846B
(zh)
*
|
2016-02-26 |
2020-10-09 |
中国医学科学院药物研究所 |
N-酰基磺酰胺类FBPase抑制剂、其制备方法、药物组合物及用途
|
|
WO2017197151A1
(en)
|
2016-05-11 |
2017-11-16 |
Emory University |
Phosphotidylinositol 3-kinase inhibitors
|
|
AU2017272505B9
(en)
|
2016-06-01 |
2021-10-28 |
Bayer Pharma Aktiengesellschaft |
Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animals
|
|
WO2018057588A1
(en)
*
|
2016-09-21 |
2018-03-29 |
Vertex Pharmaceuticals Incorporated |
Furo[3,2-b]pyridine compounds useful as inhibitors of the par-2 signaling pathway
|
|
TW201825465A
(zh)
|
2016-09-23 |
2018-07-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
TW201815787A
(zh)
|
2016-09-23 |
2018-05-01 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
TW201813963A
(zh)
|
2016-09-23 |
2018-04-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
AU2018271862B2
(en)
|
2017-05-23 |
2022-12-15 |
Mei Pharma, Inc. |
Combination therapy
|
|
MA49458A
(fr)
*
|
2017-06-21 |
2020-04-29 |
SHY Therapeutics LLC |
Composés interagissant avec la superfamille ras destinés à être utilisés dans le traitement de cancers, de maladies inflammatoires, de rasopathies et de maladies fibrotiques
|
|
JP2020531414A
(ja)
|
2017-08-14 |
2020-11-05 |
エムイーアイ ファーマ，インク． |
併用療法
|
|
CN109796465B
(zh)
*
|
2017-11-16 |
2020-07-14 |
华中科技大学同济医学院附属协和医院 |
靶向pet显像化合物、包含该化合物的显象剂及其制备方法和用途
|
|
EP3801069A4
(en)
|
2018-06-01 |
2022-03-16 |
Cornell University |
MULTIPLE THERAPY FOR DISEASE OR DISORDER ASSOCIATED WITH PI3K
|
|
CA3112177A1
(en)
|
2018-09-11 |
2020-03-19 |
Curis, Inc. |
Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety
|
|
WO2020077174A1
(en)
*
|
2018-10-12 |
2020-04-16 |
Board Of Regents Of The University Of Nebraska |
Phosphodiesterase inhibitors
|
|
EP3898609A1
(en)
|
2018-12-19 |
2021-10-27 |
Shy Therapeutics LLC |
Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
|
MX2022008627A
(es)
|
2020-01-13 |
2022-11-08 |
Verge Analytics Inc |
Pirazolo-pirimidinas sustituidas y usos de las mismas.
|
|
WO2021247841A1
(en)
*
|
2020-06-03 |
2021-12-09 |
Yumanity Therapeutics, Inc. |
Purines and methods of their use
|
|
WO2022103899A1
(en)
*
|
2020-11-10 |
2022-05-19 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
CN116981661A
(zh)
*
|
2021-03-03 |
2023-10-31 |
劲方医药科技(上海)有限公司 |
稠环取代的六元杂环化合物及其制法和用途
|
|
US20240226126A1
(en)
*
|
2021-06-16 |
2024-07-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions for treatment of psoriasis
|
|
WO2022268025A1
(zh)
*
|
2021-06-22 |
2022-12-29 |
成都苑东生物制药股份有限公司 |
Atr抑制剂及其用途
|
|
JP2024533630A
(ja)
*
|
2021-09-30 |
2024-09-12 |
ハンミ ファーマシューティカルズ カンパニー リミテッド |
ＰＩＫｆｙｖｅキナーゼ阻害剤
|
|
CN115991716B
(zh)
*
|
2021-10-19 |
2025-10-17 |
中国药科大学 |
嘧啶并环类化合物及其衍生物、制备方法、药物组合物和应用
|
|
CN118488947A
(zh)
*
|
2022-01-04 |
2024-08-13 |
劲方医药科技(上海)有限公司 |
稠环取代的六元杂环化合物及其制法和用途
|
|
CN114539293B
(zh)
*
|
2022-02-24 |
2023-09-22 |
广东晨康生物科技有限公司 |
一种噻吩并嘧啶类化合物或其药学上可接受的盐及其制备方法和应用
|
|
IL316531A
(en)
|
2022-05-11 |
2024-12-01 |
Foghorn Therapeutics Inc |
Compounds and their uses
|
|
CN117164590A
(zh)
*
|
2022-05-25 |
2023-12-05 |
沈阳药科大学 |
稠合嘧啶类衍生物及其应用
|